Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children
- PMID: 32389335
- DOI: 10.1016/j.cjca.2020.02.086
Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children
Abstract
Hypertension Canada's 2020 guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children provide comprehensive, evidence-based guidance for health care professionals and patients. Hypertension Canada develops the guidelines using rigourous methodology, carefully mitigating the risk of bias in our process. All draft recommendations undergo critical review by expert methodologists without conflict to ensure quality. Our guideline panel is diverse, including multiple health professional groups (nurses, pharmacy, academics, and physicians), and worked in concert with experts in primary care and implementation to ensure optimal usability. The 2020 guidelines include new guidance on the management of resistant hypertension and the management of hypertension in women planning pregnancy.
Copyright © 2020 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Hypertension Canada's 2020 Evidence Review and Guidelines for the Management of Resistant Hypertension.Can J Cardiol. 2020 May;36(5):625-634. doi: 10.1016/j.cjca.2020.02.083. Can J Cardiol. 2020. PMID: 32389336 Review.
-
Hypertension Canada's 2018 Guidelines for the Management of Hypertension in Pregnancy.Can J Cardiol. 2018 May;34(5):526-531. doi: 10.1016/j.cjca.2018.02.021. Epub 2018 Mar 1. Can J Cardiol. 2018. PMID: 29731014
-
Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children.Can J Cardiol. 2018 May;34(5):506-525. doi: 10.1016/j.cjca.2018.02.022. Epub 2018 Mar 1. Can J Cardiol. 2018. PMID: 29731013
-
The 2001 Canadian recommendations for the management of hypertension: Part one--Assessment for diagnosis, cardiovascular risk, causes and lifestyle modification.Can J Cardiol. 2002 Jun;18(6):604-24. Can J Cardiol. 2002. PMID: 12107419
-
The 2000 Canadian recommendations for the management of hypertension: part two--diagnosis and assessment of people with high blood pressure.Can J Cardiol. 2001 Dec;17(12):1249-63. Can J Cardiol. 2001. PMID: 11773936 Review. English, French.
Cited by
-
Synergistic effect of lipoprotein(a) and high-sensitivity C-reactive protein on the risk of all-cause and cardiovascular death in patients with acute myocardial infarction: a large prospective cohort study.Front Endocrinol (Lausanne). 2024 May 15;15:1392859. doi: 10.3389/fendo.2024.1392859. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38812817 Free PMC article.
-
Immunological insights into hypertension: unraveling triggers and potential therapeutic avenues.Hypertens Res. 2024 May 22. doi: 10.1038/s41440-024-01731-6. Online ahead of print. Hypertens Res. 2024. PMID: 38778172 Review.
-
Harmonization of clinical practice guidelines for primary prevention and screening: actionable recommendations and resources for primary care.BMC Prim Care. 2024 May 6;25(1):153. doi: 10.1186/s12875-024-02388-3. BMC Prim Care. 2024. PMID: 38711031 Free PMC article. Review.
-
Intelligent Assist Office Blood Pressures (IOBP) versus awake ambulatory monitoring and conventional auscultatory office readings in Chinese primary medical institutions.Hypertens Res. 2024 Jul;47(7):1822-1830. doi: 10.1038/s41440-024-01687-7. Epub 2024 Apr 26. Hypertens Res. 2024. PMID: 38671216
-
Outpatient management of essential hypertension: a review based on the latest clinical guidelines.Ann Med. 2024 Dec;56(1):2338242. doi: 10.1080/07853890.2024.2338242. Epub 2024 Apr 11. Ann Med. 2024. PMID: 38604225 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical